Omada Health (OMDA) Competitors

$16.56 -0.02 (-0.12%)

Closing price 04:00 PM Eastern

Extended Trading

$16.57 +0.01 (+0.03%)

As of 04:10 PM Eastern

OMDA vs. VCYT, OPCH, CON, LFST, and PRVA

Should you buy Omada Health stock or one of its competitors? MarketBeat compares Omada Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Omada Health include Veracyte (VCYT), Option Care Health (OPCH), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry.

How does Omada Health compare to Veracyte?

Veracyte (NASDAQ:VCYT) and Omada Health (NASDAQ:OMDA) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership.

Veracyte has a net margin of 16.25% compared to Omada Health's net margin of -2.22%. Veracyte's return on equity of 9.07% beat Omada Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veracyte	16.25%	9.07%	8.38%
Omada Health	-2.22%	-1.82%	-1.36%

In the previous week, Veracyte had 3 more articles in the media than Omada Health. MarketBeat recorded 10 mentions for Veracyte and 7 mentions for Omada Health. Omada Health's average media sentiment score of 0.75 beat Veracyte's score of 0.62 indicating that Omada Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veracyte	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Omada Health	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Veracyte has higher revenue and earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veracyte	$517.15M	5.94	$66.35M	$1.09	35.30
Omada Health	$260.21M	3.78	-$12.78M	-$0.27	N/A

Veracyte currently has a consensus price target of $44.83, indicating a potential upside of 16.51%. Omada Health has a consensus price target of $22.91, indicating a potential upside of 38.34%. Given Omada Health's stronger consensus rating and higher possible upside, analysts plainly believe Omada Health is more favorable than Veracyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veracyte	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38
Omada Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69

Summary

Veracyte beats Omada Health on 9 of the 13 factors compared between the two stocks.

How does Omada Health compare to Option Care Health?

Option Care Health (NASDAQ:OPCH) and Omada Health (NASDAQ:OMDA) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership and profitability.

In the previous week, Option Care Health had 7 more articles in the media than Omada Health. MarketBeat recorded 14 mentions for Option Care Health and 7 mentions for Omada Health. Option Care Health's average media sentiment score of 0.79 beat Omada Health's score of 0.75 indicating that Option Care Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Option Care Health	6 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Omada Health	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Option Care Health has a net margin of 3.64% compared to Omada Health's net margin of -2.22%. Option Care Health's return on equity of 18.17% beat Omada Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Option Care Health	3.64%	18.17%	7.16%
Omada Health	-2.22%	-1.82%	-1.36%

98.1% of Option Care Health shares are held by institutional investors. 1.7% of Option Care Health shares are held by company insiders. Comparatively, 6.4% of Omada Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Option Care Health has higher revenue and earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Option Care Health	$5.65B	0.54	$207.59M	$1.29	15.13
Omada Health	$260.21M	3.78	-$12.78M	-$0.27	N/A

Option Care Health currently has a consensus price target of $31.25, indicating a potential upside of 60.09%. Omada Health has a consensus price target of $22.91, indicating a potential upside of 38.34%. Given Option Care Health's higher probable upside, analysts plainly believe Option Care Health is more favorable than Omada Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Option Care Health	1 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.69
Omada Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69

Summary

Option Care Health beats Omada Health on 12 of the 15 factors compared between the two stocks.

How does Omada Health compare to Concentra Group Holdings Parent?

Omada Health (NASDAQ:OMDA) and Concentra Group Holdings Parent (NYSE:CON) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations.

In the previous week, Concentra Group Holdings Parent had 13 more articles in the media than Omada Health. MarketBeat recorded 20 mentions for Concentra Group Holdings Parent and 7 mentions for Omada Health. Omada Health's average media sentiment score of 0.75 beat Concentra Group Holdings Parent's score of 0.51 indicating that Omada Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Omada Health	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Concentra Group Holdings Parent	6 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Concentra Group Holdings Parent has a net margin of 7.97% compared to Omada Health's net margin of -2.22%. Concentra Group Holdings Parent's return on equity of 47.14% beat Omada Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Omada Health	-2.22%	-1.82%	-1.36%
Concentra Group Holdings Parent	7.97%	47.14%	6.48%

Concentra Group Holdings Parent has higher revenue and earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Omada Health	$260.21M	3.78	-$12.78M	-$0.27	N/A
Concentra Group Holdings Parent	$2.16B	1.53	$166.41M	$1.39	18.58

Omada Health presently has a consensus price target of $22.91, indicating a potential upside of 38.34%. Concentra Group Holdings Parent has a consensus price target of $30.25, indicating a potential upside of 17.10%. Given Omada Health's higher possible upside, equities research analysts plainly believe Omada Health is more favorable than Concentra Group Holdings Parent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Omada Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69
Concentra Group Holdings Parent	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Summary

Concentra Group Holdings Parent beats Omada Health on 9 of the 13 factors compared between the two stocks.

How does Omada Health compare to LifeStance Health Group?

LifeStance Health Group (NASDAQ:LFST) and Omada Health (NASDAQ:OMDA) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations.

85.5% of LifeStance Health Group shares are owned by institutional investors. 3.2% of LifeStance Health Group shares are owned by insiders. Comparatively, 6.4% of Omada Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

LifeStance Health Group presently has a consensus target price of $9.86, indicating a potential upside of 28.85%. Omada Health has a consensus target price of $22.91, indicating a potential upside of 38.34%. Given Omada Health's higher possible upside, analysts plainly believe Omada Health is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.00
Omada Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69

In the previous week, LifeStance Health Group had 12 more articles in the media than Omada Health. MarketBeat recorded 19 mentions for LifeStance Health Group and 7 mentions for Omada Health. Omada Health's average media sentiment score of 0.75 beat LifeStance Health Group's score of 0.43 indicating that Omada Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	5 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Omada Health	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LifeStance Health Group has a net margin of 1.55% compared to Omada Health's net margin of -2.22%. LifeStance Health Group's return on equity of 1.56% beat Omada Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	1.55%	1.56%	1.07%
Omada Health	-2.22%	-1.82%	-1.36%

LifeStance Health Group has higher revenue and earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	2.08	$9.66M	$0.06	127.50
Omada Health	$260.21M	3.78	-$12.78M	-$0.27	N/A

Summary

LifeStance Health Group beats Omada Health on 11 of the 16 factors compared between the two stocks.

How does Omada Health compare to Privia Health Group?

Privia Health Group (NASDAQ:PRVA) and Omada Health (NASDAQ:OMDA) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

In the previous week, Privia Health Group had 8 more articles in the media than Omada Health. MarketBeat recorded 15 mentions for Privia Health Group and 7 mentions for Omada Health. Omada Health's average media sentiment score of 0.75 beat Privia Health Group's score of 0.46 indicating that Omada Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Privia Health Group	7 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Omada Health	1 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

94.5% of Privia Health Group shares are held by institutional investors. 5.7% of Privia Health Group shares are held by insiders. Comparatively, 6.4% of Omada Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Privia Health Group presently has a consensus target price of $31.23, indicating a potential upside of 36.08%. Omada Health has a consensus target price of $22.91, indicating a potential upside of 38.34%. Given Omada Health's higher probable upside, analysts clearly believe Omada Health is more favorable than Privia Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Privia Health Group	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.79
Omada Health	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.69

Privia Health Group has higher revenue and earnings than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Privia Health Group	$2.25B	1.29	$22.92M	$0.16	143.44
Omada Health	$260.21M	3.78	-$12.78M	-$0.27	N/A

Privia Health Group has a net margin of 0.97% compared to Omada Health's net margin of -2.22%. Privia Health Group's return on equity of 2.81% beat Omada Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Privia Health Group	0.97%	2.81%	1.61%
Omada Health	-2.22%	-1.82%	-1.36%

Summary

Privia Health Group beats Omada Health on 11 of the 15 factors compared between the two stocks.

Get Omada Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OMDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OMDA vs. The Competition

Export

Metric	Omada Health	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$984.49M	$8.17B	$6.22B	$12.27B
Dividend Yield	N/A	3.03%	2.80%	5.35%
P/E Ratio	-61.33	20.78	20.38	25.28
Price / Sales	3.78	16.48	542.54	73.29
Price / Cash	N/A	81.29	43.26	56.33
Price / Book	4.20	5.45	9.81	6.91
Net Income	-$12.78M	$183.43M	$3.56B	$333.88M
7 Day Performance	11.74%	-1.11%	0.43%	0.16%
1 Month Performance	26.22%	8.70%	-0.87%	1.90%
1 Year Performance	N/A	2.01%	36.28%	32.84%

Omada Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OMDA Omada Health	3.2693 of 5 stars	$16.56 -0.1%	$22.91 +38.3%	N/A	$984.49M	$260.21M	N/A	849
VCYT Veracyte	2.8275 of 5 stars	$39.70 -1.8%	$44.83 +12.9%	+36.5%	$3.23B	$517.15M	36.42	790
OPCH Option Care Health	4.9333 of 5 stars	$19.83 -3.3%	$31.25 +57.6%	-37.2%	$3.22B	$5.65B	15.37	8,266
CON Concentra Group Holdings Parent	3.7784 of 5 stars	$24.94 +3.2%	$30.25 +21.3%	+22.4%	$3.09B	$2.16B	17.94	13,133
LFST LifeStance Health Group	4.2622 of 5 stars	$7.67 -0.4%	$10.00 +30.4%	+37.5%	$2.99B	$1.42B	127.83	10,961	Analyst Forecast Insider Trade High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OMDA) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Omada Health (OMDA) Competitors

OMDA vs. VCYT, OPCH, CON, LFST, and PRVA

How does Omada Health compare to Veracyte?

Summary

How does Omada Health compare to Option Care Health?

Summary

How does Omada Health compare to Concentra Group Holdings Parent?

Summary

How does Omada Health compare to LifeStance Health Group?

Summary

How does Omada Health compare to Privia Health Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OMDA vs. The Competition

Omada Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Omada Health (OMDA) Competitors

OMDA vs. VCYT, OPCH, CON, LFST, and PRVA

How does Omada Health compare to Veracyte?

Is VCYT or OMDA more profitable?

Does the media refer more to VCYT or OMDA?

Which has preferable valuation & earnings, VCYT or OMDA?

Do analysts prefer VCYT or OMDA?

Summary

How does Omada Health compare to Option Care Health?

Does the media refer more to OPCH or OMDA?

Is OPCH or OMDA more profitable?

Do institutionals and insiders hold more shares of OPCH or OMDA?

Which has better earnings & valuation, OPCH or OMDA?

Do analysts prefer OPCH or OMDA?

Summary

How does Omada Health compare to Concentra Group Holdings Parent?

Does the media favor OMDA or CON?

Is OMDA or CON more profitable?

Which has better earnings & valuation, OMDA or CON?

Do analysts recommend OMDA or CON?

Summary

How does Omada Health compare to LifeStance Health Group?

Do institutionals & insiders believe in LFST or OMDA?

Do analysts prefer LFST or OMDA?

Does the media prefer LFST or OMDA?

Is LFST or OMDA more profitable?

Which has preferable valuation and earnings, LFST or OMDA?

Summary

How does Omada Health compare to Privia Health Group?

Does the media refer more to PRVA or OMDA?

Do institutionals & insiders believe in PRVA or OMDA?

Do analysts prefer PRVA or OMDA?

Which has better valuation & earnings, PRVA or OMDA?

Is PRVA or OMDA more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OMDA vs. The Competition

Omada Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools